Fixed-dose combinations in diabetes - Do they improve medication adherence?

Diabetic Medicine

Volumn 27, Issue 7, 2010, Pages 735-736

  Feher, M D ^a   Munro, N ^a   Watters, K ^a  

^a CHELSEA AND WESTMINSTER HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIDIABETIC AGENT; GLIBENCLAMIDE PLUS METFORMIN; GLIMEPIRIDE PLUS PIOGLITAZONE; GLIMEPIRIDE PLUS ROSIGLITAZONE; GLIPIZIDE PLUS METFORMIN; INSULIN; METFORMIN PLUS ROSIGLITAZONE; METFORMIN PLUS SITAGLIPTIN; METFORMIN PLUS VILDAGLIPTIN; PRANDIMENT; TANDEMACT; UNCLASSIFIED DRUG;

CLINICAL TRIAL; DOSE RESPONSE; DRUG FORMULATION; EDITORIAL; GLYCEMIC CONTROL; HUMAN; HYPERGLYCEMIA; NON INSULIN DEPENDENT DIABETES MELLITUS; PATIENT COMPLIANCE; TREATMENT OUTCOME;

DIABETES MELLITUS, TYPE 2; DRUG THERAPY, COMBINATION; HUMANS; HYPERGLYCEMIA; HYPOGLYCEMIC AGENTS; MEDICATION ADHERENCE;

EID: 77954271848     PISSN: 07423071     EISSN: 14645491     Source Type: Journal    
DOI: 10.1111/j.1464-5491.2010.03023.x     Document Type: Editorial

References (6)

1. The Cochrane Library. Cochrane Database of Systematic Reviews 2005 2.
2. Scherthaner G. Fixed-dose combination therapies in the management of hyperglycaemia in Type 2 diabetes: an opportunity to improve adherence and patient care. Diabet Med 2010 27 : 739 743.
3. Ho PM, Rumsfeld JS, Masoudi FA, McClure DL, Plomondon ME, Steiner JF et al. Effect of medication non-adherence on hospitalization and mortality among patients with diabetes mellitus. Arch Intern Med 2006 166 : 1836 1841.
4. Lau DT, Nau DP. Oral anti-hyperglycemic medication non-adherence and subsequent hospitalization among individuals with type 2 diabetes. Diabetes Care 2004 27 : 2149 2153.
5. Shenolikar RA, Balkrishnan R. Oral anti-diabetes medication adherence and healthcare utilization among Medicaid-enrolled type 2 diabetic patients beginning monotherapy. Diabetes Care 2008 31 : e5.
6. Home PD, Bailey CJ, Donaldson J, Chen H, Stewart MW. A double-blind randomized study comparing the effects of continuing or not continuing rosiglitazone+metformin therapy when starting insulin therapy in people with Type 2 diabetes. Diabet Med 2007 24 : 618 625.